THE PDE4 INHIBITOR TANIMILAST SHOWS DISTINCT IMMUNOMODULATORY PROPERTIES ASSOCIATED WITH A TYPE 2 ENDOTYPE AND CD141 UPREGULATION

H. Nguyen (Brescia (BS), Italy), V. Salvi (Brescia (BS), Italy), L. Tiberio (Brescia (BS), Italy), M. Govoni (Parma (PR), Italy), G. Villetti (Parma (PR), Italy), M. Civelli (Parma (PR), Italy), I. Barbazza (Brescia (BS), Italy), C. Gaudenzi (Brescia (BS), Italy), M. Passari (Brescia (BS), Italy), T. Schioppa (Brescia (BS), Italy), F. Sozio (Brescia (BS), Italy), A. Dal Prete (Brescia (BS), Italy), S. Sozzani (Rome (RM), Italy), D. Bosisio (Brescia (BS), Italy), F. Facchinetti (Parma (PR), Italy)

Source: International Congress 2022 – Clinical and translational studies of asthma and COPD: novel mechanisms

Session: Clinical and translational studies of asthma and COPD: novel mechanisms
Session type: Oral Presentation
Number: 2258

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Nguyen (Brescia (BS), Italy), V. Salvi (Brescia (BS), Italy), L. Tiberio (Brescia (BS), Italy), M. Govoni (Parma (PR), Italy), G. Villetti (Parma (PR), Italy), M. Civelli (Parma (PR), Italy), I. Barbazza (Brescia (BS), Italy), C. Gaudenzi (Brescia (BS), Italy), M. Passari (Brescia (BS), Italy), T. Schioppa (Brescia (BS), Italy), F. Sozio (Brescia (BS), Italy), A. Dal Prete (Brescia (BS), Italy), S. Sozzani (Rome (RM), Italy), D. Bosisio (Brescia (BS), Italy), F. Facchinetti (Parma (PR), Italy). THE PDE4 INHIBITOR TANIMILAST SHOWS DISTINCT IMMUNOMODULATORY PROPERTIES ASSOCIATED WITH A TYPE 2 ENDOTYPE AND CD141 UPREGULATION. 2258

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.